New drug ITC-6146RO enters first human tests for tough cancers
Disease control
Not yet recruiting
This early-phase trial tests an experimental drug called ITC-6146RO in about 102 adults with advanced or metastatic cancers (like prostate, lung, or breast cancer) that have not improved with standard treatments. The study has two parts: first, finding a safe dose, then checking …
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC